Aarhus Universitets segl

English

Du er her: AU » Om AU » Organisation » Identifying Medications Underlying Communication Atypical...

Om AU

Identifying Medications Underlying Communication Atypicalities: A Pharmacosurveillance Study Within the FDA Adverse Event Reporting System

Publikation: Bidrag til tidsskrift/Konferencebidrag i tidsskrift /Bidrag til avis › Konferenceabstrakt i tidsskrift › Forskning › peer review

Standard

Identifying Medications Underlying Communication Atypicalities: A Pharmacosurveillance Study Within the FDA Adverse Event Reporting System. / Fusaroli, Michele; Simonsen, Arndis; Borrie, Stephanie et al.
I: Drug Safety, Bind 45, Nr. 10, 10.2022, s. 1134-1134.

Publikation: Bidrag til tidsskrift/Konferencebidrag i tidsskrift /Bidrag til avis › Konferenceabstrakt i tidsskrift › Forskning › peer review

Harvard

Fusaroli, M, Simonsen, A, Borrie, S, Low, D, Parola, A, Raschi, E, Poluzzi, E & Fusaroli, R 2022, 'Identifying Medications Underlying Communication Atypicalities: A Pharmacosurveillance Study Within the FDA Adverse Event Reporting System', Drug Safety, bind 45, nr. 10, s. 1134-1134. https://doi.org/10.1101/2022.09.05.22279609

APA

Fusaroli, M., Simonsen, A., Borrie, S., Low, D., Parola, A., Raschi, E., Poluzzi, E., & Fusaroli, R. (2022). Identifying Medications Underlying Communication Atypicalities: A Pharmacosurveillance Study Within the FDA Adverse Event Reporting System. Drug Safety, 45(10), 1134-1134. https://doi.org/10.1101/2022.09.05.22279609

CBE

Fusaroli M, Simonsen A, Borrie S, Low D, Parola A, Raschi E, Poluzzi E, Fusaroli R. 2022. Identifying Medications Underlying Communication Atypicalities: A Pharmacosurveillance Study Within the FDA Adverse Event Reporting System. Drug Safety. 45(10):1134-1134. https://doi.org/10.1101/2022.09.05.22279609

MLA

Fusaroli, Michele et al. "Identifying Medications Underlying Communication Atypicalities: A Pharmacosurveillance Study Within the FDA Adverse Event Reporting System". Drug Safety. 2022, 45(10). 1134-1134. https://doi.org/10.1101/2022.09.05.22279609

Vancouver

Fusaroli M, Simonsen A, Borrie S, Low D, Parola A, Raschi E et al. Identifying Medications Underlying Communication Atypicalities: A Pharmacosurveillance Study Within the FDA Adverse Event Reporting System. Drug Safety. 2022 okt.;45(10):1134-1134. doi: 10.1101/2022.09.05.22279609

Author

Fusaroli, Michele ; Simonsen, Arndis ; Borrie, Stephanie et al. / Identifying Medications Underlying Communication Atypicalities : A Pharmacosurveillance Study Within the FDA Adverse Event Reporting System. I: Drug Safety. 2022 ; Bind 45, Nr. 10. s. 1134-1134.

Bibtex

@article{82571614fa664d4a85d3821c64c0b028,
title = "Identifying Medications Underlying Communication Atypicalities: A Pharmacosurveillance Study Within the FDA Adverse Event Reporting System",
author = "Michele Fusaroli and Arndis Simonsen and Stephanie Borrie and Daniel Low and Alberto Parola and E. Raschi and E. Poluzzi and Riccardo Fusaroli",
year = "2022",
month = oct,
doi = "10.1101/2022.09.05.22279609",
language = "English",
volume = "45",
pages = "1134--1134",
journal = "Drug Safety",
issn = "0114-5916",
publisher = "Adis International Ltd",
number = "10",
note = "21st ISoP Annual Meeting {\textquoteleft}{\textquoteleft}A New Era of Pharmacovigilance:<br/>Challenges and Opportunities{\textquoteright}{\textquoteright} ; Conference date: 20-09-2022 Through 23-09-2022",

}

RIS

TY - ABST

T1 - Identifying Medications Underlying Communication Atypicalities

T2 - 21st ISoP Annual Meeting ‘‘A New Era of Pharmacovigilance:<br/>Challenges and Opportunities’’

AU - Fusaroli, Michele

AU - Simonsen, Arndis

AU - Borrie, Stephanie

AU - Low, Daniel

AU - Parola, Alberto

AU - Raschi, E.

AU - Poluzzi, E.

AU - Fusaroli, Riccardo

PY - 2022/10

Y1 - 2022/10

U2 - 10.1101/2022.09.05.22279609

DO - 10.1101/2022.09.05.22279609

M3 - Conference abstract in journal

VL - 45

SP - 1134

EP - 1134

JO - Drug Safety

JF - Drug Safety

SN - 0114-5916

IS - 10

Y2 - 20 September 2022 through 23 September 2022

ER -